These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3606637)

  • 1. The influence of digoxin-specific antibody fragments on digoxin disposition in the rat.
    Johnston PC; Stevenson IH; Hewick DS
    Biochem Pharmacol; 1987 Jul; 36(13):2215-20. PubMed ID: 3606637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of drug-specific active immunization on digoxin and benzylpenicillin disposition in the bile duct-cannulated rat.
    Johnston PC; Stevenson IH; Hewick DS
    J Pharm Pharmacol; 1988 Nov; 40(11):771-5. PubMed ID: 2907556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of digoxin dosage on the digoxin-quinidine interaction in the bile duct-cannulated rat.
    Hewick DS; Ostenfeld T
    J Pharm Pharmacol; 1987 Jan; 39(1):64-7. PubMed ID: 2880991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and kinetics of distribution and elimination of sheep digoxin-specific IgG and Fab fragments in the rabbit and baboon.
    Smith TW; Lloyd BL; Spicer N; Haber E
    Clin Exp Immunol; 1979 Jun; 36(3):384-96. PubMed ID: 114346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of immunization with digoxin-specific antibodies on digoxin disposition in the mouse.
    Griffiths NM; Hewick DS; Stevenson IH
    Biochem Pharmacol; 1984 Oct; 33(19):3041-6. PubMed ID: 6487355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of an enzyme-linked immunosorbent assay to study the disposition of sheep digoxin-specific immunoglobulin G and Fab fragments in the rat.
    Johnston PC; Stevenson IH; Hewick DS
    Clin Exp Immunol; 1988 Dec; 74(3):489-93. PubMed ID: 3233793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments.
    Ochs HR; Smith TW
    J Clin Invest; 1977 Dec; 60(6):1303-13. PubMed ID: 914999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The plasma disposition and renal elimination of digoxin-specific Fab fragments and digoxin in the rabbit.
    Timsina MP; Hewick DS
    J Pharm Pharmacol; 1992 Oct; 44(10):796-800. PubMed ID: 1360503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of digoxin-specific Fab: effects of decreased renal function and age.
    Renard C; Grene-Lerouge N; Beau N; Baud F; Scherrmann JM
    Br J Clin Pharmacol; 1997 Aug; 44(2):135-8. PubMed ID: 9278197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sheep digoxin-specific antibodies and their Fab fragments on digoxin pharmacokinetics in dogs.
    Butler VP; Schmidt DH; Smith TW; Haber E; Raynor BD; Demartini P
    J Clin Invest; 1977 Feb; 59(2):345-59. PubMed ID: 299860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of digoxin antibodies on digoxin disposition and effect: studies in guinea-pigs and HeLa cells.
    Griffiths NM; Hewick DS; Lamb JF; Stevenson IH
    Br J Pharmacol; 1985 Jan; 84(1):157-63. PubMed ID: 3978308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic aspects of digoxin-specific Fab therapy in the management of digitalis toxicity.
    Ujhelyi MR; Robert S
    Clin Pharmacokinet; 1995 Jun; 28(6):483-93. PubMed ID: 7656506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fab-bound colchicine appears to adopt Fab fragment disposition in rats.
    Sabouraud AE; Urtizberea M; Benmoussa K; Cano NJ; Scherrmann JM
    J Pharm Pharmacol; 1992 Dec; 44(12):1015-9. PubMed ID: 1361548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of the Fab fragments of digoxin antibodies and of bound digoxin in patients with severe digoxin intoxication.
    Schaumann W; Kaufmann B; Neubert P; Smolarz A
    Eur J Clin Pharmacol; 1986; 30(5):527-33. PubMed ID: 3758140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of digitalis effects by specific antibodies.
    Larbig D; Raff U; Haasis R
    Pharmacology; 1979; 18(1):1-8. PubMed ID: 368816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin-specific antibody fragments in the treatment of digoxin toxicity.
    Chan BS; Buckley NA
    Clin Toxicol (Phila); 2014; 52(8):824-36. PubMed ID: 25089630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of enzyme-linked immunosorbent assays to study the plasma disposition of sheep polyclonal and rat monoclonal digoxin-specific Fab fragments in the rabbit.
    Timsina MP; Hewick DS
    J Pharm Pharmacol; 1990 Aug; 42(8):572-6. PubMed ID: 1981586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal secretion of digoxin in the rat. Augmentation by feeding activated charcoal.
    Caldwell JH; Caldwell PB; Murphy JW; Beachler CW
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jul; 312(3):271-5. PubMed ID: 7402369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fab antibody fragments: some applications in clinical toxicology.
    Flanagan RJ; Jones AL
    Drug Saf; 2004; 27(14):1115-33. PubMed ID: 15554746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of digoxin in the rat.
    Harrison LI; Gibaldi M
    Drug Metab Dispos; 1976; 4(1):88-93. PubMed ID: 3407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.